Handelsbanken Fonder AB Cuts Position in Royalty Pharma plc

Handelsbanken Fonder AB lessened its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 891,918 shares of the biopharmaceutical company’s stock after selling 39,718 shares during the quarter. Handelsbanken Fonder AB’s holdings in Royalty Pharma were worth $25,054,000 as of its most […]

Related Keywords

United States , America , , Institute For Wealth Management , Holdings Channel , Jpmorgan Chase Co , Securities Exchange Commission , Goldman Sachs Group , Daiwa Securities Group Inc , Nasdaq , Lindbrook Capital , Handelsbanken Fonder , Royalty Pharma , Free Report , Wealth Management , Daiwa Securities Group , Securities Group , Get Free Report , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Rprx , Finance , 76028h20 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,